Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Class A common stock, par value $0.0001 per share
-
Shares outstanding
-
1.26M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
4.39M
-
Shares change
-
+4.39M
-
Total reported value, excl. options
-
$43.5M
-
Value change
-
+$43.5M
-
Number of buys
-
18
-
Price
-
$9.92
Significant Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) as of Q2 2022
18 filings reported holding DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share as of Q2 2022.
Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.39M shares
.
Largest 10 shareholders include Context Capital Management, LLC (605K shares), Hudson Bay Capital Management LP (500K shares), BOOTHBAY FUND MANAGEMENT, LLC (470K shares), ATW SPAC MANAGEMENT LLC (470K shares), Saba Capital Management, L.P. (410K shares), Polar Asset Management Partners Inc. (350K shares), Starboard Value LP (300K shares), Taconic Capital Advisors LP (258K shares), TWO SIGMA INVESTMENTS, LP (250K shares), and OAKTREE CAPITAL MANAGEMENT LP (225K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.